-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On March 23, the State Food and Drug Administration issued an announcement on revising the instructions for mouse nerve growth factor for injection, and decided to revise the instructions for mouse nerve growth factor for injection [adverse reactions], [precautions] and medications for special populations.
[Note] stressed that the increase "should be strictly in accordance with the instructions prescribed dosage administered strictly forbidden to change the route of administration.
Revision requirements of the instructions for mouse nerve growth factor for injection
Revision requirements of the instructions for mouse nerve growth factor for injection[Adverse reactions] should include the following:
Systemic diseases and various reactions at the administration site: fever, chills, chest tightness, fatigue, peripheral edema; pain at the injection site, rash at the injection site, induration at the injection site, swelling at the injection site, itching at the injection site, pain in the lower extremity of the injection side, etc.
Skin and subcutaneous tissue diseases: itching, maculopapular rash, urticaria, erythema, etc.
Neuropsychiatric diseases: dizziness, headache, local numbness, limb tremor, convulsions, insomnia, excitement, sleep disorders, mental disorders, etc.
Gastrointestinal diseases: nausea, vomiting, abdominal pain, diarrhea and other gastrointestinal reactions, elevated transaminase, abnormal liver function.
Various musculoskeletal and connective tissue diseases: muscle pain, etc.
Immune system diseases: allergic-like reactions, anaphylactic shock, etc.
Others: conjunctival hyperemia, palpitations, arrhythmia, dyspnea, laryngeal edema, granulocytosis, thrombocytosis, abnormal renal function, etc.
【Precautions】
Increase "should be strictly predetermined according to the use amount of administration instructions.
Medicine route.
The expressions "this product has the effect of promoting growth and development on the nervous system" and "please follow the doctor's advice" are deleted, and the content related to this special group of people is reserved.
【Children's Medication】
Only keep the relevant statements that there are no medication data for children.
(Note: If the other contents of the manual are inconsistent with the above revision requirements, they should be revised together.
